3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
5
Melanoma
4
Glioblastoma
4
Carcinoma
4
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Neoplasms
2
Fibrolamellar hepatocellular carcinoma
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Merkel Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms, Squamous Cell
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Interventions
Paclitaxel
40
Carboplatin
34
Bevacizumab
29
liposomal doxorubicin
20
Specimen Handling
18
Taxes
17
olaparib
16
Magnetic Resonance Spectroscopy
16
pembrolizumab
15
Gemcitabine
15
Topotecan
13
Immunoglobulin G
11
Disulfides
11
Biopsy
11
mirvetuximab soravtansine
8
niraparib
7
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
poly ICLC
×
1 year
×
Clear all
No trials found.